Search

Search Constraints

You searched for: Author/Creator Capdevila, Jaume

Search Results

4. Impact of circulating tumor DNA mutant allele fraction on prognosis in RAS‐mutant metastatic colorectal cancer. Issue 9 (31st July 2019)

5. Prognostic and predictive biomarkers for somatostatin analogs, peptide receptor radionuclide therapy and serotonin pathway targets in neuroendocrine tumours. (November 2018)

6. Analysis of KRAS, NRAS, BRAF, PIK3CA and TP53 mutations in a large prospective series of locally advanced rectal cancer patients. Issue 1 (5th July 2019)

7. Economics of gastroenteropancreatic neuroendocrine tumors: a systematic review. (February 2019)

8. VITAL phase 2 study: Upfront 5‐fluorouracil, mitomycin‐C, panitumumab and radiotherapy treatment in nonmetastatic squamous cell carcinomas of the anal canal (GEMCAD 09‐02). (18th December 2019)

9. Compliance, acute toxicity and postoperative complications of short-course radiotherapy followed by chemotherapy and surgery for high-risk rectal cancer. results of the randomized RAPIDO-trial. Issue 2 (February 2020)

10. Compliance and tolerability of short-course radiotherapy followed by preoperative chemotherapy and surgery for high-risk rectal cancer – Results of the international randomized RAPIDO-trial. (June 2020)